The Food and Drug Administration has announced that the asthma drug Xolair may increase the risk of patients developing a host of cardiovascular problems. Data gathered from clinic trials showed that Xolair users were disproportionately more likely to suffer from blood clots, heart failure, stroke, cardiac arrhythmias and heart enlargement

Back to Blog
Contact us media
Accessibility: If you are vision-impaired or have some other impairment covered by the Americans with Disabilities Act or a similar law, and you wish to discuss potential accommodations related to using this website, please contact our Accessibility Manager at (214) 333-3333.
Contact Us